Index
1 Market Overview of T-Cell Therapy
1.1 T-Cell Therapy Market Overview
1.1.1 T-Cell Therapy Product Scope
1.1.2 T-Cell Therapy Market Status and Outlook
1.2 Global T-Cell Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global T-Cell Therapy Market Size by Region (2018-2029)
1.4 Global T-Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global T-Cell Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, T-Cell Therapy Market Size (2018-2029)
1.6.1 North America T-Cell Therapy Market Size (2018-2029)
1.6.2 Europe T-Cell Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific T-Cell Therapy Market Size (2018-2029)
1.6.4 Latin America T-Cell Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa T-Cell Therapy Market Size (2018-2029)
2 T-Cell Therapy Market by Type
2.1 Introduction
2.1.1 CAR T Cell Therapy
2.1.2 TCR Therapy
2.1.3 TIL Therapy
2.2 Global T-Cell Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global T-Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global T-Cell Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa T-Cell Therapy Revenue Breakdown by Type (2018-2029)
3 T-Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics & Ambulatory Centers
3.1.3 Cancer Research Institutes
3.1.4 Others
3.2 Global T-Cell Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global T-Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global T-Cell Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa T-Cell Therapy Revenue Breakdown by Application (2018-2029)
4 T-Cell Therapy Competition Analysis by Players
4.1 Global T-Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2022)
4.3 Date of Key Players Enter into T-Cell Therapy Market
4.4 Global Top Players T-Cell Therapy Headquarters and Area Served
4.5 Key Players T-Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 T-Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gilead Sciences, Inc.
5.1.1 Gilead Sciences, Inc. Profile
5.1.2 Gilead Sciences, Inc. Main Business
5.1.3 Gilead Sciences, Inc. T-Cell Therapy Products, Services and Solutions
5.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Gilead Sciences, Inc. Recent Developments
5.2 Sorrento Therapeutics
5.2.1 Sorrento Therapeutics Profile
5.2.2 Sorrento Therapeutics Main Business
5.2.3 Sorrento Therapeutics T-Cell Therapy Products, Services and Solutions
5.2.4 Sorrento Therapeutics T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Sorrento Therapeutics Recent Developments
5.3 Fate Therapeutics Inc.
5.3.1 Fate Therapeutics Inc. Profile
5.3.2 Fate Therapeutics Inc. Main Business
5.3.3 Fate Therapeutics Inc. T-Cell Therapy Products, Services and Solutions
5.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis International AG Recent Developments
5.4 Novartis International AG
5.4.1 Novartis International AG Profile
5.4.2 Novartis International AG Main Business
5.4.3 Novartis International AG T-Cell Therapy Products, Services and Solutions
5.4.4 Novartis International AG T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis International AG Recent Developments
5.5 AbbVie Inc.
5.5.1 AbbVie Inc. Profile
5.5.2 AbbVie Inc. Main Business
5.5.3 AbbVie Inc. T-Cell Therapy Products, Services and Solutions
5.5.4 AbbVie Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 AbbVie Inc. Recent Developments
5.6 Adaptimmune Therapeutics PLC
5.6.1 Adaptimmune Therapeutics PLC Profile
5.6.2 Adaptimmune Therapeutics PLC Main Business
5.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Products, Services and Solutions
5.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Adaptimmune Therapeutics PLC Recent Developments
5.7 Bluebird Bio
5.7.1 Bluebird Bio Profile
5.7.2 Bluebird Bio Main Business
5.7.3 Bluebird Bio T-Cell Therapy Products, Services and Solutions
5.7.4 Bluebird Bio T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Bluebird Bio Recent Developments
5.8 TCR2 Therapeutics, Inc.
5.8.1 TCR2 Therapeutics, Inc. Profile
5.8.2 TCR2 Therapeutics, Inc. Main Business
5.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Products, Services and Solutions
5.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 TCR2 Therapeutics, Inc. Recent Developments
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Profile
5.9.2 Pfizer Inc. Main Business
5.9.3 Pfizer Inc. T-Cell Therapy Products, Services and Solutions
5.9.4 Pfizer Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Inc. Recent Developments
5.10 DiaCarta, Inc.
5.10.1 DiaCarta, Inc. Profile
5.10.2 DiaCarta, Inc. Main Business
5.10.3 DiaCarta, Inc. T-Cell Therapy Products, Services and Solutions
5.10.4 DiaCarta, Inc. T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 DiaCarta, Inc. Recent Developments
6 North America
6.1 North America T-Cell Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe T-Cell Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America T-Cell Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 T-Cell Therapy Market Dynamics
11.1 T-Cell Therapy Industry Trends
11.2 T-Cell Therapy Market Drivers
11.3 T-Cell Therapy Market Challenges
11.4 T-Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List